Luke Gerges DO, Presenter: Nothing to Disclose

Maryam Gul, Abstract Co-Author: Nothing to Disclose

Ammar Ahmed Chaudhry MD, Abstract Co-Author: Nothing to Disclose

Jung Hwoon Edward Yoon MD, Abstract Co-Author: Nothing to Disclose

David Schulsinger, Abstract Co-Author: Nothing to Disclose

John Alexander Ferretti MD, Abstract Co-Author: Nothing to Disclose

1- Review indications, interventional methods, contraindications, complications, pearls and pitfalls of percutaneous cryoablation. 2- Cryoablation was previously not recommended for perivascular and pericolonic neoplasms due to heat sink effects and potential damage to adjacent organs. We will discuss novel approach to treat these previously "do NOT cryoablate" lesions and how to minimize potential risks while obtaining an appropriate size ablation zone. 3- Algorithm to help determine the best treatment modality in managing renal masses.

A. Anatomy- Effect of cryoablation on vessels, small and large intestines, abdominal wall, etc. B. Clinical Findings secondary to mass effect, obstruction, vessel invasion, etc. C. Highlight imaging findings (e.g. significance of fat planes) that serve as key to patient inclusion and exclusion criteria. D. Pathophysiology: Cryobiology: Intra- and extracellular mechanisms that promote tumor cell death E. Procedure Technique: discuss key do’s and don’ts e.g. not crossing peritoneal reflections, not ablating needle tract, etc. F. Follow-up: Immediate post-procedure management and follow-up guidelines G. Outcomes:      a. Complications: Immediate (hemorrhage, recurrence, bowel perforation, etc), Delayed (recurrence, fistulas, etc)      b. Survival 

http://abstract.rsna.org/uploads/2014/14001832/14001832_e5tq.pdf

Gerges, L, Gul, M, Chaudhry, A, Yoon, J, Schulsinger, D, Ferretti, J, Cryoablation of Exophytic Neoplasms: Novel Minimally Invasive Approach to Treat Unresectable Tumors.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14001832.html